COVID-19 Funding Opportunities
University of Kentucky Internal Pilot Funding
- UK CCTS / COBRE -The Center for Biomedical Research Excellence on Obesity and Cardiovascular Diseases (COCVD) Pilot Project Funding Opportunity
- UK CURE - COVID-19 Pilot Program, Core 3- Social Sciences
- The University of Kentucky Center for Clinical and Translational Sciences - UK CURE COVID-19 Pilot Program
- UK CURE - COVID-19 Pilot Program, Core 2-Materials/Methods
Agency for Healthcare Research and Quality (AHRQ)
- Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
- Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
American Arbitration Association-International Centre for Dispute Resolution Foundation (AAA-ICDR Foundation)
American Association of Colleges of Nursing
American Thoracic Society (ATS) Foundation
Biomedical Advanced Research and Development Authority (BARDA)
- Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Amendment 17 (COVID-19 Areas of Interest) Deadline: October 31, 2020
Centers for Disease Control and Prevention
Coalition for Epidemic Preparedness Innovation
Department of Commerce / Economic Development Administration
Department of Defense/MTEC
- Potential Topics of Upcoming Funding Opportunities in 2020
- Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response
- DoD- CDMRP - FY20 PRMRP Focus Areas for Emerging Viral Diseases and Respiratory Health
- FY20 Peer Reviewed Medical Research Program (PRMRP) Investigator-Initiated Research Award - Deadline 09/03/20
- FY20 Peer Reviewed Medical Research Program (PRMRP) Technology/ Therapeutic Development Award - Deadline 09/03/20
Department of Health and Human Services
Office of the Assistant Secretary for Health
Emergent Ventures
Foundation for Opioid Response Efforts (FORE)
Joint European Disruptive Initiative
John Hopkins School of Nursing and others
Merck KGaA
Multi-Agency - Operation Warp Speed
- Broad Agency Announcement (BAA) Supporting Research for the U.S. Department of Health and Human Services Under Contracts, Other Transaction Agreements and Technology Investment Agreements for the Treatment and Protection from COVID-19- Deadline: August 01, 2022.
National Institutes of Health
- NIH - Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
- Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) 09/30/2020
- Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) Deadline 09/15/2020
- Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) Deadline 09/18/2020
- Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Deadline 09/15/2020
- Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) Deadline 09/15/2020
- Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) Deadline: 09/15/2020
- Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (Rolling Deadline)
- Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool. Deadline: 09/16/2020
- Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). Deadline: 8/22/2020
- NIH/NIAID Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (Please note that NOT-AI-20-059 replaces NOT-AI-20-034 which has been rescinded, effective immediately) Deadline: 07/02/2021
- Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) - Deadline 08/15/2020
- Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project. Deadlines: 11/12/20, 3/12/21, 7/12/21
- NIH – Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) Deadlines: August 8/20/2020, and 8/02/2020, and 03/02/2021
- NIH – Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) - PAR-20-237- Deadline: 08/28/2020; 12/01/2020
- NIH - Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) – PAR-20-229 -Deadline 08/14/2020
- NIH Common Fund – NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) – RFA-RM-20-021
- Cisco Research Center (CRC) – Pandemic/COVID19 Science, Technology and Social Impact
- Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need- Deadline 11/11/2020
- NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) - Deadline 07/01/2020, and again the first working day of each month through 02/01/2021
- Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations- Deadline 09/09/2020
- Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations - Deadline 09/09/2020
- Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations - Deadline 08/08/2020
- Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations - Deadline 12/30/2020
- Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 - Deadline 12/30/2020
- Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders - Deadline 09/08/22
- Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)"
- NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
- Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) Deadline: August 18, 2020
- Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- NINDS - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
- NIAID - Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
- NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials
- NLM - Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)
- Common Fund - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- NIAAA - Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA
- OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
- NCCIH, NIA, NIAAA - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
- NIBIB - Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- NIBIB - Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- NIBIB - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
- NIMHD, NIA, NIMH - Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
- NIMH, NIA, NIAAA, NIMHD - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
- NIA, NIMH, NIAAA - Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- NCATS - Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
- NIDA -NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- NHLBI -NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- NIAID, NIA - Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
- NIAID -NIH Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
- NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB, Common Fund, NCATS, NIAAA - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- 2020 NIAID Omnibus Broad Agency Announcement
- NIEHS Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
- NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCD, NCI, NIDCR -NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
- NIIAD - NIH Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
National Science Foundation
- NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
- Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
Robert Wood Johnson Foundation
- Emergency Response for the General Public Innovation Challenge
- Emergency Response for the Health Care System Innovation Challenge